Jenna Payesko

The FDA has granted QIDP and Fast Track Designations for the oral formulation of SCY-078 for the treatment of vulvovaginal candidiasis.

The FDA has accepted for review the NDA for Mayne Pharma’s SUBA-Itraconazole capsules for the treatment of 3 systemic fungal infections.

If this indication is approved, physicians will be able to reserve the vaccine for young children to protect them against the 2019-2020 flu season.

On the heels of revealing a new feature promoting HIV testing, a data analysis finds that the app was sharing sensitive information with other companies.

Implementation of a rapid entry program decreased time to first provider appointment, time to initiation of ART, and time to viral suppression in the Southern United States.

Recent research presented at CROI 2018 finds that the risk of female HIV acquisition per sex act steadily increased through pregnancy and was highest during postpartum.

Researchers discuss a new method to rapidly detect HIV time-space clusters for public health intervention at CROI 2018.

Mental health is a critical component of ending the HIV epidemic.

At CROI 2018, the World Health Organization released updated guidelines for cryptococcal disease in HIV-infected adults.

A recent study finds a potential link between cannabis use and possible beneficial reduction in systemic inflammation and immune activation in ART-treated HIV patients.

The FDA has approved Firvanq for the treatment of C. diff-associated diarrhea and enterocolitis caused by Staphylococcus aureus.

GlaxoSmithKline has announced that the FDA's Center for Biologics Evaluation and Research has approved expanding the indication for their influenza vaccine to include use in those 6 months of age and older.

The FDA has just approved the first two-drug regimen for treating certain individuals living with HIV.

Why is delafloxacin unique compared to other fluoroquinolones? Find out more.

Surotomycin fails to show benefit over vancomycin for the treatment of Clostridium difficile infection in a phase 3 trial.

Made of a flexible silicone material, the ring contains dapivirine, a non-nucleoside reverse transcriptase inhibitor that blocks HIV’s ability to replicate inside of a healthy cell.

Bacterial vaginosis is the most common gynecologic infection in the United States, affecting 21 million women between the ages of 14 and 49, each year.